Cargando…
P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431575/ http://dx.doi.org/10.1097/01.HS9.0000970708.04566.c4 |
| _version_ | 1785091233568260096 |
|---|---|
| author | Paiva, Bruno Zherniakova, Anastasiia Nuñez, Jorge Rodríguez-Otero, Paula Shi, Qian Munshi, Nikhil Durie, Brian San Miguel, Jesús |
| author_facet | Paiva, Bruno Zherniakova, Anastasiia Nuñez, Jorge Rodríguez-Otero, Paula Shi, Qian Munshi, Nikhil Durie, Brian San Miguel, Jesús |
| author_sort | Paiva, Bruno |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104315752023-08-17 P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) Paiva, Bruno Zherniakova, Anastasiia Nuñez, Jorge Rodríguez-Otero, Paula Shi, Qian Munshi, Nikhil Durie, Brian San Miguel, Jesús Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431575/ http://dx.doi.org/10.1097/01.HS9.0000970708.04566.c4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Paiva, Bruno Zherniakova, Anastasiia Nuñez, Jorge Rodríguez-Otero, Paula Shi, Qian Munshi, Nikhil Durie, Brian San Miguel, Jesús P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title | P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title_full | P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title_fullStr | P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title_full_unstemmed | P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title_short | P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM) |
| title_sort | p951: impact of measurable residual disease (mrd) differences on progression-free survival (pfs): an aggregate data analysis from randomized clinical trials in multiple myeloma (mm) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431575/ http://dx.doi.org/10.1097/01.HS9.0000970708.04566.c4 |
| work_keys_str_mv | AT paivabruno p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT zherniakovaanastasiia p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT nunezjorge p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT rodriguezoteropaula p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT shiqian p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT munshinikhil p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT duriebrian p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm AT sanmigueljesus p951impactofmeasurableresidualdiseasemrddifferencesonprogressionfreesurvivalpfsanaggregatedataanalysisfromrandomizedclinicaltrialsinmultiplemyelomamm |